| Molecular Formula | C16H11N3O5S |
| Molar Mass | 357.34 |
| Density | 1.68±0.1 g/cm3(Predicted) |
| Melting Point | 259-261° |
| Boling Point | 554.7±60.0 °C(Predicted) |
| Solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
| Appearance | Solid |
| Color | Off-White to Pale Yellow |
| pKa | 3.80±0.19(Predicted) |
| Storage Condition | 2-8°C |
| Physical and Chemical Properties | Crystallized from acetone, melting point 259~261 ℃. Acute toxicity LD50 male and female mice, male and female mice (mg/kg):6192,8841,1434,1994 oral administration. |
| Toxicity | LD50 orally in male, female mice, and male, female rats: 6192, 8841, 1434, 1994 mg/kg (Soler, 1986) |
| Use | is a prodrug of piroxicam that functions in the stomach by conversion to piroxicam. For anti-inflammatory. |
| production method | by the compound (I) and phenyl N-(2-pyridyl) carbamate, it is obtained by refluxing in dipolyethylene glycol dimethyl ether. |